Registered number
14269943
Eveready Pharma Ltd
Filleted Accounts
31 December 2024
Eveready Pharma Ltd
Registered number: 14269943
Balance Sheet
as at 31 December 2024
Notes 2024 2023
£ £
Fixed assets
Intangible assets 3 624,376 -
Tangible assets 4 162,864 -
787,240 -
Current assets
Stocks 41,250 -
Debtors 5 190,916 -
Cash at bank and in hand 302,686 2
534,852 2
Creditors: amounts falling due within one year 6 (394,461) -
Net current assets 140,391 2
Total assets less current liabilities 927,631 2
Creditors: amounts falling due after more than one year 7 (743,328) -
Net assets 184,303 2
Capital and reserves
Called up share capital 2 2
Profit and loss account 184,301 -
Shareholders' funds 184,303 2
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr Rachinder Singh Judge
Director
Approved by the board on 15 September 2025
Eveready Pharma Ltd
Notes to the Accounts
for the year ended 31 December 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery over 5 years
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
Leased assets
A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership. All other leases are classified as operating leases. The rights of use and obligations under finance leases are initially recognised as assets and liabilities at amounts equal to the fair value of the leased assets or, if lower, the present value of the minimum lease payments. Minimum lease payments are apportioned between the finance charge and the reduction in the outstanding liability using the effective interest rate method. The finance charge is allocated to each period during the lease so as to produce a constant periodic rate of interest on the remaining balance of the liability. Leased assets are depreciated in accordance with the company's policy for tangible fixed assets. If there is no reasonable certainty that ownership will be obtained at the end of the lease term, the asset is depreciated over the lower of the lease term and its useful life. Operating lease payments are recognised as an expense on a straight line basis over the lease term.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 4 1
3 Intangible fixed assets £
Goodwill:
Cost
Additions 657,238
At 31 December 2024 657,238
Amortisation
Provided during the year 32,862
At 31 December 2024 32,862
Net book value
At 31 December 2024 624,376
Goodwill is being written off in equal annual instalments over its estimated economic life.
4 Tangible fixed assets
Plant and machinery etc
£
Cost
Additions 203,580
At 31 December 2024 203,580
Depreciation
Charge for the year 40,716
At 31 December 2024 40,716
Net book value
At 31 December 2024 162,864
5 Debtors 2024 2023
£ £
Trade debtors 123,814 -
Vat Recoverable 10,969 -
Other debtors 56,133 -
190,916 -
6 Creditors: amounts falling due within one year 2024 2023
£ £
Trade creditors 184,500 -
Director's Account 53,975 -
Taxation and social security costs 27,761 -
Other creditors 128,225 -
394,461 -
7 Creditors: amounts falling due after one year 2024 2023
£ £
Other creditors 743,328 -
8 Related party transactions
Other creditors includes the amount of £ 243.428 due to RSJ Pharma Ltd. Mr R S Judge is a Director of the company and holds a material interest. There are no terms as to interest or repayment in respect of this amount.
9 Other information
Eveready Pharma Ltd is a private company limited by shares and incorporated in England. Its registered office is:
Laxmi House
2-b Draycott Avenue
Kenton Harrow
Middlesex
HA3 0BU
Eveready Pharma Ltd 14269943 false 2024-01-01 2024-12-31 2024-12-31 VT Final Accounts April 2025 Mr Rachinder Singh Judge No description of principal activity 14269943 2023-01-01 2023-12-31 14269943 core:WithinOneYear 2023-12-31 14269943 core:AfterOneYear 2023-12-31 14269943 core:ShareCapital 2023-12-31 14269943 core:RetainedEarningsAccumulatedLosses 2023-12-31 14269943 2024-01-01 2024-12-31 14269943 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 14269943 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 14269943 bus:Director40 2024-01-01 2024-12-31 14269943 1 2024-01-01 2024-12-31 14269943 2 2024-01-01 2024-12-31 14269943 core:Goodwill 2024-01-01 2024-12-31 14269943 core:PlantMachinery 2024-01-01 2024-12-31 14269943 countries:England 2024-01-01 2024-12-31 14269943 bus:FRS102 2024-01-01 2024-12-31 14269943 bus:FilletedAccounts 2024-01-01 2024-12-31 14269943 2024-12-31 14269943 core:WithinOneYear 2024-12-31 14269943 core:AfterOneYear 2024-12-31 14269943 core:ShareCapital 2024-12-31 14269943 core:RetainedEarningsAccumulatedLosses 2024-12-31 14269943 core:Goodwill 2024-12-31 14269943 core:PlantMachinery 2024-12-31 14269943 2023-12-31 iso4217:GBP xbrli:pure